Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Complex Percutaneous Coronary Intervention Revenue 1.4 Market Analysis by Type 1.4.1 Global Complex Percutaneous Coronary Intervention Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Drug-Eluting Stents (DES) 1.4.3 Bare Metal Stents 1.4.4 Bioresorbable Stents 1.5 Market by Application 1.5.1 Global Complex Percutaneous Coronary Intervention Market Share by Application: 2020 VS 2026 1.5.2 Percutaneous Coronary Intervention (PCI) 1.5.3 Transcatheter Aortic Valve Implantation (TAVI/TAVR) 1.5.4 Trans-Mitral Valve Implantation (TMVR) 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Complex Percutaneous Coronary Intervention Market Perspective (2015-2026) 2.2 Complex Percutaneous Coronary Intervention Growth Trends by Regions 2.2.1 Complex Percutaneous Coronary Intervention Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Complex Percutaneous Coronary Intervention Historic Market Share by Regions (2015-2020) 2.2.3 Complex Percutaneous Coronary Intervention Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Complex Percutaneous Coronary Intervention Market Growth Strategy 2.3.6 Primary Interviews with Key Complex Percutaneous Coronary Intervention Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Complex Percutaneous Coronary Intervention Players by Market Size 3.1.1 Global Top Complex Percutaneous Coronary Intervention Players by Revenue (2015-2020) 3.1.2 Global Complex Percutaneous Coronary Intervention Revenue Market Share by Players (2015-2020) 3.1.3 Global Complex Percutaneous Coronary Intervention Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Complex Percutaneous Coronary Intervention Market Concentration Ratio 3.2.1 Global Complex Percutaneous Coronary Intervention Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Complex Percutaneous Coronary Intervention Revenue in 2019 3.3 Complex Percutaneous Coronary Intervention Key Players Head office and Area Served 3.4 Key Players Complex Percutaneous Coronary Intervention Product Solution and Service 3.5 Date of Enter into Complex Percutaneous Coronary Intervention Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Complex Percutaneous Coronary Intervention Historic Market Size by Type (2015-2020) 4.2 Global Complex Percutaneous Coronary Intervention Forecasted Market Size by Type (2021-2026) 5 Complex Percutaneous Coronary Intervention Breakdown Data by Application (2015-2026) 5.1 Global Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) 5.2 Global Complex Percutaneous Coronary Intervention Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Complex Percutaneous Coronary Intervention Market Size (2015-2020) 6.2 Complex Percutaneous Coronary Intervention Key Players in North America (2019-2020) 6.3 North America Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) 6.4 North America Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) 7 Europe 7.1 Europe Complex Percutaneous Coronary Intervention Market Size (2015-2020) 7.2 Complex Percutaneous Coronary Intervention Key Players in Europe (2019-2020) 7.3 Europe Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) 7.4 Europe Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) 8 China 8.1 China Complex Percutaneous Coronary Intervention Market Size (2015-2020) 8.2 Complex Percutaneous Coronary Intervention Key Players in China (2019-2020) 8.3 China Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) 8.4 China Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) 9 Japan 9.1 Japan Complex Percutaneous Coronary Intervention Market Size (2015-2020) 9.2 Complex Percutaneous Coronary Intervention Key Players in Japan (2019-2020) 9.3 Japan Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) 9.4 Japan Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Complex Percutaneous Coronary Intervention Market Size (2015-2020) 10.2 Complex Percutaneous Coronary Intervention Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) 10.4 Southeast Asia Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) 11 India 11.1 India Complex Percutaneous Coronary Intervention Market Size (2015-2020) 11.2 Complex Percutaneous Coronary Intervention Key Players in India (2019-2020) 11.3 India Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) 11.4 India Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Complex Percutaneous Coronary Intervention Market Size (2015-2020) 12.2 Complex Percutaneous Coronary Intervention Key Players in Central & South America (2019-2020) 12.3 Central & South America Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) 12.4 Central & South America Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Abbott Laboratories 13.1.1 Abbott Laboratories Company Details 13.1.2 Abbott Laboratories Business Overview and Its Total Revenue 13.1.3 Abbott Laboratories Complex Percutaneous Coronary Intervention Introduction 13.1.4 Abbott Laboratories Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020)) 13.1.5 Abbott Laboratories Recent Development 13.2 Medtronic 13.2.1 Medtronic Company Details 13.2.2 Medtronic Business Overview and Its Total Revenue 13.2.3 Medtronic Complex Percutaneous Coronary Intervention Introduction 13.2.4 Medtronic Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) 13.2.5 Medtronic Recent Development 13.3 Boston Scientific 13.3.1 Boston Scientific Company Details 13.3.2 Boston Scientific Business Overview and Its Total Revenue 13.3.3 Boston Scientific Complex Percutaneous Coronary Intervention Introduction 13.3.4 Boston Scientific Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) 13.3.5 Boston Scientific Recent Development 13.4 B. Braun Melsungen 13.4.1 B. Braun Melsungen Company Details 13.4.2 B. Braun Melsungen Business Overview and Its Total Revenue 13.4.3 B. Braun Melsungen Complex Percutaneous Coronary Intervention Introduction 13.4.4 B. Braun Melsungen Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) 13.4.5 B. Braun Melsungen Recent Development 13.5 Biosensors International 13.5.1 Biosensors International Company Details 13.5.2 Biosensors International Business Overview and Its Total Revenue 13.5.3 Biosensors International Complex Percutaneous Coronary Intervention Introduction 13.5.4 Biosensors International Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) 13.5.5 Biosensors International Recent Development 13.6 Biotronik 13.6.1 Biotronik Company Details 13.6.2 Biotronik Business Overview and Its Total Revenue 13.6.3 Biotronik Complex Percutaneous Coronary Intervention Introduction 13.6.4 Biotronik Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) 13.6.5 Biotronik Recent Development 13.7 Terumo 13.7.1 Terumo Company Details 13.7.2 Terumo Business Overview and Its Total Revenue 13.7.3 Terumo Complex Percutaneous Coronary Intervention Introduction 13.7.4 Terumo Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) 13.7.5 Terumo Recent Development 13.8 Johnson & Johnson 13.8.1 Johnson & Johnson Company Details 13.8.2 Johnson & Johnson Business Overview and Its Total Revenue 13.8.3 Johnson & Johnson Complex Percutaneous Coronary Intervention Introduction 13.8.4 Johnson & Johnson Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) 13.8.5 Johnson & Johnson Recent Development 13.9 Getinge 13.9.1 Getinge Company Details 13.9.2 Getinge Business Overview and Its Total Revenue 13.9.3 Getinge Complex Percutaneous Coronary Intervention Introduction 13.9.4 Getinge Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) 13.9.5 Getinge Recent Development 13.10 Abbott 13.10.1 Abbott Company Details 13.10.2 Abbott Business Overview and Its Total Revenue 13.10.3 Abbott Complex Percutaneous Coronary Intervention Introduction 13.10.4 Abbott Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) 13.10.5 Abbott Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Complex Percutaneous Coronary Intervention Key Market Segments Table 2. Key Players Covered: Ranking by Complex Percutaneous Coronary Intervention Revenue Table 3. Ranking of Global Top Complex Percutaneous Coronary Intervention Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Complex Percutaneous Coronary Intervention Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Drug-Eluting Stents (DES) Table 6. Key Players of Bare Metal Stents Table 7. Key Players of Bioresorbable Stents Table 8. Global Complex Percutaneous Coronary Intervention Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Complex Percutaneous Coronary Intervention Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Complex Percutaneous Coronary Intervention Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Complex Percutaneous Coronary Intervention Market Share by Regions (2015-2020) Table 12. Global Complex Percutaneous Coronary Intervention Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Complex Percutaneous Coronary Intervention Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Complex Percutaneous Coronary Intervention Market Growth Strategy Table 18. Main Points Interviewed from Key Complex Percutaneous Coronary Intervention Players Table 19. Global Complex Percutaneous Coronary Intervention Revenue by Players (2015-2020) (Million US$) Table 20. Global Complex Percutaneous Coronary Intervention Market Share by Players (2015-2020) Table 21. Global Top Complex Percutaneous Coronary Intervention Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Complex Percutaneous Coronary Intervention as of 2019) Table 22. Global Complex Percutaneous Coronary Intervention by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Complex Percutaneous Coronary Intervention Product Solution and Service Table 25. Date of Enter into Complex Percutaneous Coronary Intervention Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$) Table 28. Global Complex Percutaneous Coronary Intervention Market Size Share by Type (2015-2020) Table 29. Global Complex Percutaneous Coronary Intervention Revenue Market Share by Type (2021-2026) Table 30. Global Complex Percutaneous Coronary Intervention Market Size Share by Application (2015-2020) Table 31. Global Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$) Table 32. Global Complex Percutaneous Coronary Intervention Market Size Share by Application (2021-2026) Table 33. North America Key Players Complex Percutaneous Coronary Intervention Revenue (2019-2020) (Million US$) Table 34. North America Key Players Complex Percutaneous Coronary Intervention Market Share (2019-2020) Table 35. North America Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$) Table 36. North America Complex Percutaneous Coronary Intervention Market Share by Type (2015-2020) Table 37. North America Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$) Table 38. North America Complex Percutaneous Coronary Intervention Market Share by Application (2015-2020) Table 39. Europe Key Players Complex Percutaneous Coronary Intervention Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Complex Percutaneous Coronary Intervention Market Share (2019-2020) Table 41. Europe Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$) Table 42. Europe Complex Percutaneous Coronary Intervention Market Share by Type (2015-2020) Table 43. Europe Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$) Table 44. Europe Complex Percutaneous Coronary Intervention Market Share by Application (2015-2020) Table 45. China Key Players Complex Percutaneous Coronary Intervention Revenue (2019-2020) (Million US$) Table 46. China Key Players Complex Percutaneous Coronary Intervention Market Share (2019-2020) Table 47. China Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$) Table 48. China Complex Percutaneous Coronary Intervention Market Share by Type (2015-2020) Table 49. China Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$) Table 50. China Complex Percutaneous Coronary Intervention Market Share by Application (2015-2020) Table 51. Japan Key Players Complex Percutaneous Coronary Intervention Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Complex Percutaneous Coronary Intervention Market Share (2019-2020) Table 53. Japan Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$) Table 54. Japan Complex Percutaneous Coronary Intervention Market Share by Type (2015-2020) Table 55. Japan Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$) Table 56. Japan Complex Percutaneous Coronary Intervention Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Complex Percutaneous Coronary Intervention Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Complex Percutaneous Coronary Intervention Market Share (2019-2020) Table 59. Southeast Asia Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Complex Percutaneous Coronary Intervention Market Share by Type (2015-2020) Table 61. Southeast Asia Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Complex Percutaneous Coronary Intervention Market Share by Application (2015-2020) Table 63. India Key Players Complex Percutaneous Coronary Intervention Revenue (2019-2020) (Million US$) Table 64. India Key Players Complex Percutaneous Coronary Intervention Market Share (2019-2020) Table 65. India Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$) Table 66. India Complex Percutaneous Coronary Intervention Market Share by Type (2015-2020) Table 67. India Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$) Table 68. India Complex Percutaneous Coronary Intervention Market Share by Application (2015-2020) Table 69. Central & South America Key Players Complex Percutaneous Coronary Intervention Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Complex Percutaneous Coronary Intervention Market Share (2019-2020) Table 71. Central & South America Complex Percutaneous Coronary Intervention Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Complex Percutaneous Coronary Intervention Market Share by Type (2015-2020) Table 73. Central & South America Complex Percutaneous Coronary Intervention Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Complex Percutaneous Coronary Intervention Market Share by Application (2015-2020) Table 75. Abbott Laboratories Company Details Table 76. Abbott Laboratories Business Overview Table 77. Abbott Laboratories Product Table 78. Abbott Laboratories Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) (Million US$) Table 79. Abbott Laboratories Recent Development Table 80. Medtronic Company Details Table 81. Medtronic Business Overview Table 82. Medtronic Product Table 83. Medtronic Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) (Million US$) Table 84. Medtronic Recent Development Table 85. Boston Scientific Company Details Table 86. Boston Scientific Business Overview Table 87. Boston Scientific Product Table 88. Boston Scientific Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) (Million US$) Table 89. Boston Scientific Recent Development Table 90. B. Braun Melsungen Company Details Table 91. B. Braun Melsungen Business Overview Table 92. B. Braun Melsungen Product Table 93. B. Braun Melsungen Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) (Million US$) Table 94. B. Braun Melsungen Recent Development Table 95. Biosensors International Company Details Table 96. Biosensors International Business Overview Table 97. Biosensors International Product Table 98. Biosensors International Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) (Million US$) Table 99. Biosensors International Recent Development Table 100. Biotronik Company Details Table 101. Biotronik Business Overview Table 102. Biotronik Product Table 103. Biotronik Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) (Million US$) Table 104. Biotronik Recent Development Table 105. Terumo Company Details Table 106. Terumo Business Overview Table 107. Terumo Product Table 108. Terumo Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) (Million US$) Table 109. Terumo Recent Development Table 110. Johnson & Johnson Business Overview Table 111. Johnson & Johnson Product Table 112. Johnson & Johnson Company Details Table 113. Johnson & Johnson Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) (Million US$) Table 114. Johnson & Johnson Recent Development Table 115. Getinge Company Details Table 116. Getinge Business Overview Table 117. Getinge Product Table 118. Getinge Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) (Million US$) Table 119. Getinge Recent Development Table 120. Abbott Company Details Table 121. Abbott Business Overview Table 122. Abbott Product Table 123. Abbott Revenue in Complex Percutaneous Coronary Intervention Business (2015-2020) (Million US$) Table 124. Abbott Recent Development Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global Complex Percutaneous Coronary Intervention Market Share by Type: 2020 VS 2026 Figure 2. Drug-Eluting Stents (DES) Features Figure 3. Bare Metal Stents Features Figure 4. Bioresorbable Stents Features Figure 5. Global Complex Percutaneous Coronary Intervention Market Share by Application: 2020 VS 2026 Figure 6. Percutaneous Coronary Intervention (PCI) Case Studies Figure 7. Transcatheter Aortic Valve Implantation (TAVI/TAVR) Case Studies Figure 8. Trans-Mitral Valve Implantation (TMVR) Case Studies Figure 9. Complex Percutaneous Coronary Intervention Report Years Considered Figure 10. Global Complex Percutaneous Coronary Intervention Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Complex Percutaneous Coronary Intervention Market Share by Regions: 2020 VS 2026 Figure 12. Global Complex Percutaneous Coronary Intervention Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Complex Percutaneous Coronary Intervention Market Share by Players in 2019 Figure 15. Global Top Complex Percutaneous Coronary Intervention Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Complex Percutaneous Coronary Intervention as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Complex Percutaneous Coronary Intervention Revenue in 2019 Figure 17. North America Complex Percutaneous Coronary Intervention Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Complex Percutaneous Coronary Intervention Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Complex Percutaneous Coronary Intervention Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Complex Percutaneous Coronary Intervention Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Complex Percutaneous Coronary Intervention Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Complex Percutaneous Coronary Intervention Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Complex Percutaneous Coronary Intervention Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Abbott Laboratories Revenue Growth Rate in Complex Percutaneous Coronary Intervention Business (2015-2020) Figure 26. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Medtronic Revenue Growth Rate in Complex Percutaneous Coronary Intervention Business (2015-2020) Figure 28. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Boston Scientific Revenue Growth Rate in Complex Percutaneous Coronary Intervention Business (2015-2020) Figure 30. B. Braun Melsungen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. B. Braun Melsungen Revenue Growth Rate in Complex Percutaneous Coronary Intervention Business (2015-2020) Figure 32. Biosensors International Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Biosensors International Revenue Growth Rate in Complex Percutaneous Coronary Intervention Business (2015-2020) Figure 34. Biotronik Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Biotronik Revenue Growth Rate in Complex Percutaneous Coronary Intervention Business (2015-2020) Figure 36. Terumo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Terumo Revenue Growth Rate in Complex Percutaneous Coronary Intervention Business (2015-2020) Figure 38. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Johnson & Johnson Revenue Growth Rate in Complex Percutaneous Coronary Intervention Business (2015-2020) Figure 40. Getinge Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Getinge Revenue Growth Rate in Complex Percutaneous Coronary Intervention Business (2015-2020) Figure 42. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Abbott Revenue Growth Rate in Complex Percutaneous Coronary Intervention Business (2015-2020) Figure 44. Bottom-up and Top-down Approaches for This Report Figure 45. Data Triangulation Figure 46. Key Executives Interviewed

Abbott Laboratories Medtronic Boston Scientific B. Braun Melsungen Biosensors International Biotronik Terumo Johnson & Johnson Getinge Abbott